<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In a prospective study twenty patients with benign intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo>, 15 females and five males with mean age 34 years (range 12-61 years), were followed up from 12 to 61 months (mean 22 months) </plain></SENT>
<SENT sid="1" pm="."><plain>Initially <z:hpo ids='HP_0000001'>all</z:hpo> patients showed marked <z:hpo ids='HP_0001085'>papilledema</z:hpo>, <z:mpath ids='MPATH_458'>normal</z:mpath> visual acuity, considerable enlargement of the blind spot area, and significantly delayed pattern reversal visual evoked potentials </plain></SENT>
<SENT sid="2" pm="."><plain>During medical treatment eleven patients showed within 3-6 months a rapidly regression and normalization of <z:hpo ids='HP_0001085'>papilledema</z:hpo>, blind spot area, and visual evoked potentials </plain></SENT>
<SENT sid="3" pm="."><plain>Eight patients continued in showing <z:hpo ids='HP_0001085'>papilledema</z:hpo> including disc <z:hpo ids='HP_0002171'>gliosis</z:hpo>, enlargement of blind spot area, and pathological visual evoked potentials </plain></SENT>
<SENT sid="4" pm="."><plain>One patient developed <z:hpo ids='HP_0000648'>optic nerve atrophy</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The results indicated that repeated examinations of visual evoked potentials, when suspect of threatening <z:hpo ids='HP_0000572'>visual loss</z:hpo> has come up (<z:hpo ids='HP_0001085'>papilledema</z:hpo>, increased blind spot area, and field defects), might increase the change of diagnose of an <z:hpo ids='HP_0000648'>optic nerve atrophy</z:hpo> as early as possible </plain></SENT>
</text></document>